FOXO3 programs tumor-associated DCs to become tolerogenic in human and murine prostate cancer
- Type
- Retraction
- Notice date
- 5/1/2015 0:00
- Journal
- The Journal of Clinical Investigation (JCI)
- Publisher
- American Society for Clinical Investigation
- Notice DOI
- 10.1172/jci81878
- Original paper DOI
- 10.1172/jci44325